期刊文献+

苏尼替尼对HeLa细胞中的CDK4的影响

Effects of Sutent on the CDK4 in HeLa Cell
下载PDF
导出
摘要 以不同浓度的Sutent作用于HeLa细胞,采用MTT法检测Sutent对HeLa细胞增殖的影响.流式细胞术检测Sutent对HeLa细胞周期的影响;Western免疫印迹检测不同浓度的Sutent对HeLa细胞中CDK4蛋白表达的变化;探讨苏尼替尼(Sutent)对HeLa细胞中CDK4的影响.结果表明Sutent能够抑制HeLa细胞的增殖,引起HeLa细胞发生G2期周期阻滞,并且呈浓度依赖性降低HeLa细胞中CDK4蛋白表达量.显示了Sutent作为多靶点药物在药物研发中具有潜在的重要的研究价值. In this paper we studied the effects of Sutent on the CDK4 in cervical cancer HeLa cells. HeLa cells were treated with Sutent at various concentrations respectively and the growth inhibitory rate of cells was evaluated by MTT assay. The cell cycle of HeLa ceils was studied by flow cytometry. The protein expressions of CDK4 were detected by Western blot. Sutent showed dose-dependent inhibitory effect on both the proliferations and cellcycle arrest at G2/M in HeLa cells. Western blot revealed that Sutent decreased the protein expressions of CDK4 with the increase of concentration. This is important for Sutent to be applied in drug discovery field as multi-target drug.
出处 《吉林师范大学学报(自然科学版)》 2013年第1期84-86,共3页 Journal of Jilin Normal University:Natural Science Edition
基金 国家自然科学基金项目(50573030)
关键词 苏尼替尼 CDK4 细胞增殖 细胞周期 Western免疫印迹 Sutent CDK4 proliferation cell cycle western blot
  • 相关文献

参考文献8

  • 1Hartmann JT,Kanz L. Sunitinib and periodic hair depigmentation due to temporary c-KIT inhibition[J].Archives of Dermatology,2008,(11):1525-1526.
  • 2Quek R,George S. Gastrointestinal stromal tumor:a clinical overview[J].Hematology/Oncology Clinics of North America,2009,(01):69-78.
  • 3Blay J Y,Reichardt P. Advanced gastrointestinal stromal tumor in Europe:a review of updated treatment recommendations[J].Expert Review of Anticancer Therapy,2009,(06):831-838.
  • 4Gan K H,Seruga B,Knox JJ. Sunitinib in solid tumors[J].Expert Opinion on Investigational Drugs,2009,(06):821-834.doi:10.1517/13543780902980171.
  • 5Gfana X. Find all citations by this author (default).Or filter your current search Reddy EP.Cell cycle control in mammalian cells:role of cyclins,cyclin dependent kinases (CDKs),growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)[J].Oncogene,1995,(02):211-219.
  • 6Pavletich P N. Mechanisms of cyclin-dependent kinase regulation:structures of cdks,their cyclin activators,and cip and INK4 inhibitors[J].Journal of Molecular Biology,1999,(05):821-828.doi:10.1006/jmbi.1999.2640.
  • 7Lin L,Czerwinski R,Kelleher K. Activation Loop Phosphorylation Modulates Bruton~ Tyrosine Kinase (Btk) Kinase Domain Activity[J].Biochemistry,2009,(09):2021-2032.
  • 8Morgan J A. Patients with imatinib mesy late resistant GIST exhibit durableresponses to sunitinib malate (SU 11248)[J].European Journal of Cancer,2005.S421.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部